Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

US Patent 11833136 · Granted Dec 5, 2023

Estimated economic value: $533,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic uses of glucokinase activators in combination with insulin or insuli2024
Therapeutic uses of glucokinase activators in combination with insulin or insuli2024
Boron-containing small molecules as antiprotozoal agents2021
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2021
Glucokinase activator compositions for the treatment of diabetes2021
Therapeutic uses of glucokinase activators in combination with insulin or insuli2021
Therapeutic uses of glucokinase activators in combination with insulin or insuli2021
Boron-containing small molecules as antiprotozoal agents2020
Glucokinase activator compositions for the treatment of diabetes2020
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2019
Compositions comprising metformin and a glucokinase activator2019
Boron containing small molecules as antiprotozoal agents2019